Jasmiel and Necitumumab Intravenous
Determining the interaction of Jasmiel and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: drospirenone / ethinyl estradiol
Brand name: Gianvi, Jasmiel, Loryna, Nikki, Ocella, Syeda, Vestura, Yasmin, Yaz, Zarah, Lo-Zumandimine, Zumandimine, Ocella, Yasmin 28, Yaz
Synonyms: n.a.
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jasmiel-Necon
- Jasmiel-Necon 0.5/35
- Jasmiel-Necon 1/35
- Jasmiel-Necon 1/50
- Jasmiel-Necon 1/50 (28)
- Jasmiel-Necon 7/7/7
- Necitumumab Intravenous-Jatenzo
- Necitumumab Intravenous-Jay-Phyl
- Necitumumab Intravenous-Jay-Phyl Syrup
- Necitumumab Intravenous-Jencycla
- Necitumumab Intravenous-Jentadueto
- Necitumumab Intravenous-Jentadueto XR